Helicobacter Pylori Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Helicobacter Pylori Diagnostics Market is segmented By Technology (Immunoassays, Point of Care (POC), Molecular diagnostics, Others), By End-user and Geography

Helicobacter Pylori Diagnostics Market Snapshot

Helicobacter Pylori Diagnostics Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Helicobacter Pylori Diagnostics Market is expected to register a CAGR of 7.2% during the forecast period. Helicobacter pylori is a gram-negative aerobic bacterium commonly found in the stomach which plays a key role in balancing stomach ecology. Helicobacter pylori cause changes to the stomach and duodenum and infect the protective tissue that lines the stomach leading to the chronic inflammation in the walls of the stomach (gastritis) or duodenum (duodenitis). Approximately 80–95% of people with ulcers are infected with Helicobacter pylori. Left untreated, Helicobacter pylori infection may lead to stomach cancer. Helicobacter pylori are probably spread by consuming water or food which is contaminated with fecal matter. According to some researchers, about half of the world's population may be affected by Helicobacter Pylori. Approximately 90 percent of these people do not experience problems, according to the American Academy of Family Physicians. There are several ways to diagnose Helicobacter pylori most used tests are breath tests, stool tests, and blood tests.

According to the National Institute for Health Research, prevalence of Helicobacter pylori is high in most of the countries such as north European and North American populations, about one-third of adults are still infected, whereas, in South America, Asia, and south and east Europe, the prevalence of Helicobacter pylori is higher than 50%. In addition, Helicobacter pylori remain highly prevalent in immigrants coming from countries with a high prevalence of Helicobacter pylori.

Rising prevalence of infectious diseases, improved cost-effectiveness of diagnosis of helicobacter pylori infection and increasing awareness about the infections among people are the key driving factors in helicobacter pylori diagnostics market.

Scope of the Report

Helicobacter pylori is a gram-negative aerobic bacterium commonly found in the stomach which plays a key role in balancing stomach ecology. Helicobacter Pylori Diagnostics Market is segmented By Technology, End-user, and Geography.

By Technology
Immunoassays
Point of Care (POC)
Molecular diagnostics
Others
By End-user
Hospitals and clinics
Diagnostic laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Immunoassay Segment is Expected to Witness a Healthy CAGR

An immunoassay is a biochemical test that measures the concentration or presence of a macromolecule in a solution through the use of an antibody or an antigen. This assay can be used for diagnosis of a disease directly, by measuring the presence of antigens. According to the Centers for Disease Control and Prevention (CDC), estimates that about two-thirds of the world’s population harbors the bacterium, with infection rates much higher in developing countries than in developed nations. The International Agency for Research on Cancer, classified Helicobacter pylori as a carcinogen, or cancer-causing agent, in humans.

Immunoassay segment hold a significant market share in the helicobacter pylori diagnostics market and is anticipated to show similar trend over the forecast period due to presence of several advanced technologies such as the enzyme immunoassays which are used for the detection of antibodies. Rising prevalence of Helicobacter pylori infections and technological advancements are the key driving factors in the immunoassay segment.

Helicobacter Pylori Diagnostics Market

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the helicobacter pylori diagnostics market due to the increasing prevalence of Helicobacter Pylori infections and rising awareness regarding Helicobacter pylori infections in this region. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in the United States, about half of people over the age of 60 years and 20 percent of people under the age of 40 years are infected with Helicobacter Pylori. Moreover, technological advancements in the Helicobacter pylori diagnostics and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

Helicobacter Pylori Diagnostics Market 2

Competitive Landscape

The Helicobacter Pylori Diagnostics Market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Quest Diagnostics Incorporate, Meridian Bioscience, F. Hoffmann-La Roche, Biohit Oyj, CorisBioConcept SPRL, CerTest BIOTEC, Epitope Diagnostics, Inc and Exalenz Bioscience Ltd.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Infections Diseases

      2. 4.2.2 Increasing Awareness about the Infections Among People

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Norms by Government

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 Immunoassays

      2. 5.1.2 Point of Care (POC)

      3. 5.1.3 Molecular diagnostics

      4. 5.1.4 Others

    2. 5.2 By End-user

      1. 5.2.1 Hospitals and clinics

      2. 5.2.2 Diagnostic laboratories

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific

      2. 6.1.2 Bio-Rad Laboratories

      3. 6.1.3 Quest Diagnostics Incorporate

      4. 6.1.4 Meridian Bioscience

      5. 6.1.5 F. Hoffmann-La Roche

      6. 6.1.6 Biohit Oyj

      7. 6.1.7 CorisBioConcept SPRL

      8. 6.1.8 CerTest BIOTEC

      9. 6.1.9 Epitope Diagnostics, Inc

      10. 6.1.10 Exalenz Bioscience Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Helicobacter Pylori Diagnostics Market market is studied from 2018 - 2026.

The Helicobacter Pylori Diagnostics Market is growing at a CAGR of 7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Thermo Fisher Scientific, Bio-Rad Laboratories, Quest Diagnostics Incorporate, Meridian Bioscience, F. Hoffmann-La Roche are the major companies operating in Helicobacter Pylori Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!